☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Eli Lilly and NextCure Signs a Multi-Year Collaboration to Develop Novel Immuno-Oncology Therapies
November 6, 2018
Amgen to Present Long-Term Safety-Efficacy Data of Repatha (evolocumab) in Multiple studies- at AHA 2018
November 6, 2018
Abeona Signs Exclusive License Agreement with Regenxbio to Develop and Commercialize NAV AAV9 vector
November 6, 2018
Merck Signs a Clinical Trial Collaboration with FLX Bio- for a Combination Therapy
November 6, 2018
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions